Works matching IS 20457634 AND DT 2023 AND VI 12 AND IP 24

Results: 69
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Retraction.

    Published in:
    2023
    Publication type:
    Correction Notice
    20
    21
    22
    23

    Apalutamide for prostate cancer: Multicentre and multidisciplinary real‐world study of 227 patients.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 24, p. 21969, doi. 10.1002/cam4.6769
    By:
    • Sánchez, Julián Córdoba;
    • Picola, Natalia;
    • Rodriguez‐Vida, Alejo;
    • Costa, Marc;
    • Castañeda, David Marmolejo;
    • Márquez, Meritxell Pérez;
    • Rodriguez, Jesús Muñoz;
    • Gaya, J. M.;
    • Bravo, Alejandra;
    • Buisan, Oscar;
    • Servian, Pol;
    • Suarez, Jose Francisco;
    • Felip, Mireia Musquera;
    • Caparrós, Maria Jose Ribal;
    • Asensio, Antonio Alcaraz;
    • Vilaseca, Antoni
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    First impressions: A prospective evaluation of patient–physician concordance and satisfaction following the initial medical oncology consultation.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 24, p. 22293, doi. 10.1002/cam4.6758
    By:
    • Bach, Yvonne;
    • Panov, Elan;
    • Espin‐Garcia, Osvaldo;
    • Chen, Eric;
    • Krzyzanowska, Monika;
    • O'Kane, Grainne;
    • Moore, Malcolm;
    • Prince, Rebecca M.;
    • Knox, Jennifer;
    • Grant, Robert;
    • Ma, Lucy X.;
    • Allen, Michael J.;
    • Eng, Lawson;
    • Kosyachkova, Ekaterina;
    • Megid, Thais Baccili Cury;
    • Barron, Carly;
    • Wang, Xin;
    • Saltiel, Marie‐Philippe;
    • Farooq, Abdul Rehman Rehman;
    • Jang, Raymond W.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Yokohama, Keisuke;
    • Nishikawa, Hiroki
    Publication type:
    Article
    47
    48
    49
    50